The concern stems from its activation of the VEGFR2 pathway and FAK-paxillin signaling, which drive angiogenesis and are dysregulated in 50% of human cancers (ovarian cancer, melanoma, and colon adenocarcinoma)
Chronic exposure data in any species is insufficient to draw conclusions about carcinogenicity, organ toxicity, or endocrine disruption from prolonged BPC-157 administration
doses per vial 10 doses This calculator is provided for informational and research purposes only
If the desired results are not seen after 3-6 months, or if the patient cannot tolerate the medication, discontinuation or alternative treatments may be considered
Overall, NAD+ Injection side effects tend to be manageable, and your provider will monitor you, especially during initial doses, to ensure youre responding well